Most of the biotech and pharmaceutical companies are trying to develop an efficient drug to treat Covid-19 infection. It is the biggest opportunity for these companies to make revenue and boost the stock price.
Atossa Therapeutics is one such company that has a connection with Covid-19. It is a biotech company that is currently developing drugs to treat covid-19 patients.
Because of this reason, many investors have started investing their money in NASDAQ ATOS. This penny stock can easily benefit you if you buy the shares at the right time and sell it at the right time.
What is Atossa Therapeutics?
It is a biopharmaceutical company. This company is based in Seattle. They are mostly developing products for treating breast cancer and Covod-19 amongst patients.
This company went public in the year 2012. The shares are currently being traded on NASDAQ. The stock value of NASDAQ ATOS at https://www.webull.com/quote/nasdaq-atos has increased after it got permission from FDA to use Endoxifen for treating breast cancer.
However, they are also into developing drugs for covid-19. They are developing nasal spray for treating the covid-19 infection at home. As the company is developing innovative medicines which are different from others, many investors are turned towards the stock.
Most of the investors only want to know about Atossa Therapeutics Covid-19 treatment, as it is the need of the hour. Currently, they have two programs to treat Covid-19 symptoms.
The first one is known as “Covd-19 Hope”. This program is only for patients who are severely ill. In this treatment, they use a combination of two drugs to treat the patient. AT-H201 helps the body to block the virus, thereby serving as an antibody.
AT-H201 is approved by FDA. However, it is approved for only treating other diseases. This company also used AT-301 treatment for Covid-19 patients. It is a nasal spray for patients who are taking the treatment at home.
If the patient is not critically ill, this spray will help them to recover from the infection. As Atossa is helping all types of covid-19 patients with the help of the two programs, it has a positive impact on NASDAQ ATOS stock price.
Apart from developing covid-19 drugs, they are also into breast cancer treatment. The company have developed a drug called Endoxifen. It is an oral drug for patients suffering from breast cancer.
NASDAQ ATOS Performance:
The stock price of ATOS was $0.80 in March 2020. However, with the change in product development, the stock price increased to $4.35 in July. Its price went down in December but again came back to $4.35 in Februarys. As of now, the price is $2.63, but it will likely go up in the future. You can check more stocks like nasdaq amzn at https://www.webull.com/quote/nasdaq-amzn before investing.